Innovating Works

H2020

Cerrada
HORIZON-HLTH-2022-IND-13-02
Scaling up multi-party computation, data anonymisation techniques, and synthetic data generation
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 6 “Maintaining an innovative, sustainable and globally competitive health industry”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 41 al 60 de 230 resultados
SmartCHANGE: AI-based long-term health risk evaluation for driving behaviour change strategies in children and yo... INSTITUT JOZEF STEFAN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Non-communicable diseases (NCDs) are the leading cause of death and healthcare expense. Common risk factors for many of them are obesity and...
2023-05-01 - 2027-04-30 | Financiado
SMILE: Supporting Mental Health in Young People: Integrated Methodology for cLinical dEcisions and evidence... FTKFORSCHUNGSINSTITUT FUR TELEKOMMUNIKATION UND KOOPERATION EV tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Anxiety disorders’ diagnosis, decision and treatment processes are still uncertain and inconsistent especially in a fast-evolving real world...
2023-05-01 - 2026-10-31 | Financiado
STRATIF-AI: Continuous stratification for improved prevention, treatment, and rehabilitation of stroke patients... LINKOPINGS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage State-of-the-art stratification today is based on machine-learning (ML) algorithms, trained on large cohort data. This has two main limitati...
2023-05-01 - 2027-04-30 | Financiado
GEREMY: Gene Therapy for treatment of rare inherited Arrhythmogenic Cardiomyopathy STICHTING NETHERLANDS HEART INSTITUTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Development of a cure for rare cardiac diseases is a risky, costly and time-consuming process, which is hampered by insufficient insight int...
2023-05-01 - 2027-04-30 | Financiado
NOSEVAC: INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TR... EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Bacterial and viral respiratory infections are a leading cause of morbidity and mortality worldwide. Streptococcus pneumoniae and Bordetella...
2023-05-01 - 2028-04-30 | Financiado
ARTILLERY: Artificial Intelligence for early detection of non-communicable disease risk in people with breast c... UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage The ultimate ambition of the ARTILLERY consortium is to enhance long term health of the growing population of breast cancer survivors by mak...
2023-05-01 - 2028-04-30 | Financiado
OBELISK: Fighting childhood obesity to stay healthy all over the life INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Obesity rates in late teens have increased in Europe from 6% in 1980 to 32%, with long-lasting effects on the prevalence of severe obesity,...
2023-05-01 - 2028-04-30 | Financiado
VASCUL-AID: DEVELOPING TRUSTWORTHY ARTIFICIAL INTELLIGENCE (AI)-DRIVEN TOOLS TO PREDICT VASCULAR DISEASE RISK AN... STICHTING AMSTERDAM UMC tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage The aim of VASCUL-AID is to predict the risk of cardiovascular events and progression of the vascular diseases Abdominal Aortic Aneurysm (AA...
2023-05-01 - 2029-04-30 | Financiado
IN-ARMOR: THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESIS... HASKOLI ISLANDS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Antimicrobial resistance (AMR) & multi-drug resistance, whereby pathogens evolve to resist antibiotic drugs, is designated by WHO one of the...
2023-05-01 - 2027-04-30 | Financiado
SPIDeRR: Stratification of Patients using advanced Integrative modeling of Data Routinely acquired for diagno... ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Globally 1.Globally 1.71 billion people have musculoskeletal symptoms, the leading contributor to disability. Early disease stratification i...
2023-05-01 - 2028-04-30 | Financiado
PLACES: PLAsticity of perception in real and virtual spaCES UNIVERSITAET MUENSTER tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 Space is fundamental to physical and perceptual reality, but physical and perceptual space are not the same. Perceptual space is created by...
2023-05-01 - 2027-04-30 | Financiado
MITI 2: Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Our project focuses on the regulatory properties of a subset of microbiota-specific TR1-like regulatory T (Treg) cells, for which we have al...
2023-04-28 - 2027-04-30 | Financiado
ARTiDe: Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, with a risk of devastating complications, premature mortality, a...
2023-04-27 - 2028-06-30 | Financiado
FIBROTARGET: Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases KATHOLIEKE UNIVERSITEIT LEUVEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Fibrostenosis is the driving reason for the persistent need in bowel resections in inflammatory bowel diseases (IBD). Current IBD therapies...
2023-04-24 - 2028-03-31 | Financiado
Bootstrap: Boosting Societal Adaptation and Mental Health in a Rapidly Digitalizing Post Pandemic Europe INSTITUT CATALA DE LA SALUT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-01-two-stage BACKGROUND: Adolescents are at particularly high risk for digital technology overuse, including in response to the COVID pandemic, and are t...
2023-04-21 - 2028-06-30 | Financiado
UltiMalVax: A Vaccine Targeting Eradication of Malaria EUROPEAN VACCINE INITIATIVE E.V tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-03-two-stage Malaria killed about 640 thousand people in 2020, largely young children in Africa. Rapid recent progress has led to two anti-sporozoite vac...
2023-04-21 - 2027-04-30 | Financiado
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-02-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado
eprObes: Preventing lifetime obesity by early risk factor identification prognosis and intervention CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage Obesity is one of the main population health threats worldwide, with a sustained increase in prevalence over the last decades and a constell...
2023-04-11 - 2028-04-30 | Financiado
STRATA-FIT: Stratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies fo... UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-01-two-stage Difficult-to-treat rheumatoid arthritis (D2T RA) is an area of huge unmet medical need with major socio-economic consequences for patients a...
2023-04-07 - 2029-04-30 | Financiado
FLUTE: Federate Learning and mUlti-party computation Techniques for prostatE cancer INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-IND-13-02 The FLUTE project will advance and scale up data-driven healthcare by developing novel methods for privacy-preserving cross-border utilizati...
2023-04-04 - 2026-04-30 | Financiado